CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
CAR-CQ6924 | Anti-NCAM1 (CBX-005) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBX-005 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ7404 | Anti-NCAM1 (CBX-005) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBX-005 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY7291 | Anti-NCAM1 (CBFYA-0136) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYA-0136 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY7292 | Anti-NCAM1 (CBFYA-0137) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYA-0137 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY8089 | Anti-NCAM1 (CBFYA-0136) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYA-0136 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY8090 | Anti-NCAM1 (CBFYA-0137) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYA-0137 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MOREAngiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORETRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE